Alginate–Chitosan–PLGA Composite Microspheres Enabling Single-Shot Hepatitis B Vaccination
- 25 June 2010
- journal article
- Published by Springer Nature in The AAPS Journal
- Vol. 12 (4) , 519-524
Abstract
Hepatitis B vaccination typically requires a multi-dose administration protocol over a course of 3–6 months. Aiming at developing a single-shot formulation for hepatitis B vaccine (hepatitis B surface antigen (HBsAg)), a novel vaccine delivery system, the composite microspheres of alginate–chitosan–poly(lactic-co-glycolic acid) (PLGA), was synthesized by a two-step preparation. The composite microspheres showed distinct advantages over the conventional PLGA microspheres in aspects of the high loading capacity and the elimination of lyophilizing process. The loading capacity of the composite microspheres was about seven times higher than those in the conventional PLGA microspheres, due to the protein-friendly microenvironment created by the hydrophilic alginate–chitosan cores of the composite microspheres. This vaccine delivery system was shown to be able to induce robust immune responses by single injection and display no significant difference in HBsAg-specific antibody levels compared to the double-injection method.Keywords
This publication has 23 references indexed in Scilit:
- Treatment of hepatitis B virus-infected patients: utility of therapeutic recommendations in developing countriesExpert Opinion on Pharmacotherapy, 2009
- Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis BJournal of Controlled Release, 2009
- Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final reportVaccine, 2008
- Stabilization of Tetanus Toxoid Encapsulated in PLGA MicrospheresMolecular Pharmaceutics, 2008
- Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivativesJournal of Controlled Release, 2008
- A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese populationBMC Infectious Diseases, 2008
- Low Dose Intradermal Vaccination Is Superior to High Dose Intramuscular Vaccination for Hepatitis B in Unresponsive Hemodialysis PatientsRenal Failure, 2007
- Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccineVaccine, 2007
- Encapsulation of proteins and peptides into biodegradable poly(d,l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cellsVaccine, 2006
- In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisationVaccine, 2004